IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 275 filers reported holding IMMUNOGEN INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $804,609 | -87.8% | 50,700 | -85.5% | 0.00% | -86.7% |
| Q2 2023 | $6,583,743 | +1614.5% | 348,900 | +248.9% | 0.02% | +1400.0% |
| Q1 2023 | $384,000 | -22.3% | 100,000 | +0.3% | 0.00% | 0.0% |
| Q4 2022 | $494,279 | +106.8% | 99,653 | +99.3% | 0.00% | – |
| Q3 2022 | $239,000 | -57.8% | 50,000 | -60.3% | 0.00% | – |
| Q2 2022 | $567,000 | -4.9% | 126,016 | +0.6% | 0.00% | – |
| Q1 2022 | $596,000 | -36.9% | 125,300 | -64.0% | 0.00% | -100.0% |
| Q1 2019 | $944,000 | +250.9% | 348,167 | +1126.6% | 0.00% | – |
| Q3 2018 | $269,000 | +174.5% | 28,385 | +86.2% | 0.00% | – |
| Q4 2017 | $98,000 | – | 15,246 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |